title: A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.
abstract: OBJECTIVE
  This paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring.
  
  
  METHODS
  Data were sourced by a literature search using MEDLINE and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content.
  
  
  RESULTS
  Screening and monitoring can detect medical causes of depression. Specific adverse effects associated with antidepressant treatments may be reduced or identified earlier by baseline screening and agent-specific monitoring after commencing treatment.
  
  
  CONCLUSIONS
  The adoption of safety monitoring guidelines when treating clinical depression is likely to improve overall physical health status and treatment outcome. It is important to implement these guidelines in the routine management of clinical depression.
authors: School of Medicine, Deakin University, Geelong, Victoria, Australia.
authors: Seetal
authors: S
authors: Dodd
authors: Gin S
authors: GS
authors: Malhi
authors: John
authors: J
authors: Tiller
authors: Isaac
authors: I
authors: Schweitzer
authors: Ian
authors: I
authors: Hickie
authors: Jon Paul
authors: JP
authors: Khoo
authors: Darryl L
authors: DL
authors: Bassett
authors: Bill
authors: B
authors: Lyndon
authors: Philip B
authors: PB
authors: Mitchell
authors: Gordon
authors: G
authors: Parker
authors: Paul B
authors: PB
authors: Fitzgerald
authors: Marc
authors: M
authors: Udina
authors: Ajeet
authors: A
authors: Singh
authors: Steven
authors: S
authors: Moylan
authors: Francesco
authors: F
authors: Giorlando
authors: Carolyn
authors: C
authors: Doughty
authors: Christopher G
authors: CG
authors: Davey
authors: Michael
authors: M
authors: Theodoros
authors: Michael
authors: M
authors: Berk
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D032921:Consensus; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000628:therapy*; D006304:Health Status; D006801:Humans; D061214:Patient Safety; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents